Insider Selling: KYTHERA Biopharmaceuticals VP Sells 4,000 Shares of Stock (KYTH)
KYTHERA Biopharmaceuticals (NASDAQ:KYTH) VP Jeffrey D. Webster unloaded 4,000 shares of KYTHERA Biopharmaceuticals stock on the open market in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $45.40, for a total value of $181,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
KYTHERA Biopharmaceuticals (NASDAQ:KYTH) traded up 0.29% during mid-day trading on Tuesday, hitting $45.55. The stock had a trading volume of 94,139 shares. KYTHERA Biopharmaceuticals has a 52-week low of $14.07 and a 52-week high of $47.85. The stock’s 50-day moving average is $40.72 and its 200-day moving average is $37.46. The company’s market cap is $974.8 million.
KYTHERA Biopharmaceuticals (NASDAQ:KYTH) last released its earnings data on Thursday, November 14th. The company reported ($0.62) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.72) by $0.10. Analysts expect that KYTHERA Biopharmaceuticals will post $-2.74 EPS for the current fiscal year.
KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.